AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NIFEDIPINE USP

9 registrations across 4 African markets— 7 active

Markets with NIFEDIPINE USP

Recent registrations

Brand / ProductMarketHolderStatusExpires
NIFIDIN XR-30 TABLETS (Each extended-release tablet contains Nifedipine USP 30mg)🇬🇭GhanaactiveFeb 2031
NIFIDIN XR-30 TABLETS (Each extended-release tablet contains Nifedipine USP 30mg)🇬🇭GhanaactiveFeb 2031
NIFIDIN XR-20 TABLETS (Each extended-release tablet contains Nifedipine USP 20mg)🇬🇭GhanaactiveFeb 2031
NIFIDIN XR-20 TABLETS (Each extended-release tablet contains Nifedipine USP 20mg)🇬🇭GhanaactiveFeb 2031
Calnif retard
Tablet sustained release
🇿🇲ZambiaCadila Pharmaceuticals LimitedactiveMay 2029
NIFEMAX SR TABLETS (Each tablet contains Nifedipine USP 30mg)🇬🇭GhanaPANACEA PHARMACEUTICALS LIMITED 138 NORTH KANESHIE, ACCRA GHANAactiveApr 2029
NIFEMAX SR TABLETS (Each tablet contains Nifedipine USP 30mg)🇬🇭GhanaPANACEA PHARMACEUTICALS LIMITED 138 NORTH KANESHIE, ACCRA GHANAactiveApr 2029
LIFEBACK NIFEDIPINE RETARD TABLETS
TABLETS
🇳🇬NigeriaLIFEBACK PHARMACY & STORES LTD 36expiredFeb 2023
NIPINE-SR 20MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2020

NIFEDIPINE USP in Africa — Regulatory Overview

NIFEDIPINE USP is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.